Beranda › Gangguan Bipolar › Ohio
Uji klinis Gangguan Bipolar di Ohio
6 studi untuk Gangguan Bipolar mencari peserta di lokasi di Ohio.
Kota di Ohio
Teks studi resmi (Bahasa Inggris)
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- University of Cincinnati Medical Center, Cincinnati
- Charak Center for Health and Wellness, Garfield Heights
Menerima pesertaFase 3
Usia 10 hingga 17 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06372964Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- University of Cincinnati Medical Center, Cincinnati
- Charak Center for Health and Wellness, Garfield Heights
Menerima pesertaFase 3
Usia 5 hingga 17 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06229210A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Independence
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07105111A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
- University Of Cincinnati Medical Center /ID# 274160, Cincinnati
- The Ohio State University /ID# 272954, Columbus
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT06696755Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents
- University of Cincinnati College of Medicine, Cincinnati
Menerima pesertaMenyebutkan pembayaran untuk peserta
Usia 12 hingga 21 · Semua jenis kelamin · Diperbarui 22 Apr 2026 · NCT06920940Attentional Biases, Reward Sensitivity, and Cognitive Control in Adults With Bipolar Disorder
- University Hospitals Cleveland Medical Center - Mood Disorders Program, Cleveland
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Okt 2025 · NCT03829787Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.